Portfolio company
Epoqe Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops peptide-based heart rescue therapies to treat acute myocardial infarction for patients with cardiovascular diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cardior Pharmaceuticals
This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.
Brano Therapeutics
This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.
Serca Pharmaceuticals
This company develops cardioprotective drugs to treat patients suffering from myocardial infarction and heart failure by modulating the SERCA2 calcium pump.
Cardior
This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.
Forcefield Therapeutics
The company develops protein-based therapeutics designed to protect heart function and prevent cell death in patients following a heart attack.
NanoPhoria
This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.
ProCorde AG
This cardiovascular-focused company develops therapies for thrombosis and vascular dysfunction to treat patients suffering from coronary artery disease and other cardiovascular pathologies.
AnaCardio
This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.